174 related articles for article (PubMed ID: 7745020)
1. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors.
Mouhieddine OE; Levy L; Benlot C; Peillon F; Joubert D
J Clin Endocrinol Metab; 1995 May; 80(5):1691-5. PubMed ID: 7745020
[TBL] [Abstract][Full Text] [Related]
2. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
[TBL] [Abstract][Full Text] [Related]
3. Autocrine and paracrine effects of peptides on human pituitary cells.
Joubert D; Mouhieddine B; Benlot C; Levy L; Peillon F
Horm Res; 1992; 38(1-2):100-4. PubMed ID: 1363983
[TBL] [Abstract][Full Text] [Related]
4. Presence and characterization of the somatostatin precursor in normal human pituitaries and in growth hormone secreting adenomas.
Levy L; Bourdais J; Mouhieddine B; Benlot C; Villares S; Cohen P; Peillon F; Joubert D
J Clin Endocrinol Metab; 1993 Jan; 76(1):85-90. PubMed ID: 8093621
[TBL] [Abstract][Full Text] [Related]
5. [Neurohormones coming from the normal and tumoral human anterior pituitary. Secretion and regulation in vitro].
Peillon F; Le Dafniet M; Garnier P; Feinstein MC; Donnadieu M; Barret A; Gautron JP; Brandi AM; Benlot C; Lagoguey A
Pathol Biol (Paris); 1989 Sep; 37(7):840-5. PubMed ID: 2576565
[TBL] [Abstract][Full Text] [Related]
6. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor.
Torronteras R; Gracia-Navarro F; Elsaesser F
Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989
[TBL] [Abstract][Full Text] [Related]
7. The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids.
Lamberts SW; den Holder F; Hofland LJ
Endocrinology; 1989 Feb; 124(2):905-11. PubMed ID: 2492219
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin and growth hormone-releasing hormone in normal and tumoral human breast tissue: endogenous content, in vitro pulsatile release, and regulation.
Benlot C; Lévy L; Fontanaud P; Roche A; Rouannet P; Joubert D
J Clin Endocrinol Metab; 1997 Feb; 82(2):690-6. PubMed ID: 9024278
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
Moyse E; Le Dafniet M; Epelbaum J; Pagesy P; Peillon F; Kordon C; Enjalbert A
J Clin Endocrinol Metab; 1985 Jul; 61(1):98-103. PubMed ID: 2860120
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone-releasing hormone and somatostatin in normal and tumoral human pituitaries.
Benlot C; Pagesy P; Peillon F; Joubert-Bression D
Peptides; 1991; 12(5):945-50. PubMed ID: 1686935
[TBL] [Abstract][Full Text] [Related]
12. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
[TBL] [Abstract][Full Text] [Related]
13. Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat.
Bertherat J; Timsit J; Bluet-Pajot MT; Mercadier JJ; Gourdji D; Kordon C; Epelbaum J
J Clin Invest; 1993 Apr; 91(4):1783-91. PubMed ID: 8097209
[TBL] [Abstract][Full Text] [Related]
14. [In vitro secretion of somatostatin (SRIH) by human adenomatous somatotropic cells. Relation with somatotropic hormone (GH) release and modulation by thyroliberin (TRH)].
Peillon F; Liappi G; Garnier P; Brandi AM; Evain-Brion D; Dodeur M; Gautron JP; Donnadieu M; Michard M; Racadot J
C R Acad Sci III; 1988; 306(4):161-6. PubMed ID: 2896067
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
Kelijman M; Williams TC; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
Florio T; Thellung S; Corsaro A; Bocca L; Arena S; Pattarozzi A; Villa V; Massa A; Diana F; Schettini D; Barbieri F; Ravetti JL; Spaziante R; Giusti M; Schettini G
Clin Endocrinol (Oxf); 2003 Jul; 59(1):115-28. PubMed ID: 12807513
[TBL] [Abstract][Full Text] [Related]
17. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F
J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptides of anterior pituitary origin. Autocrine or paracrine functions?
Peillon F; Le Dafniet M; Pagesy P; Li JY; Benlot C; Brandi AM; Joubert D
Pathol Res Pract; 1991 Jun; 187(5):577-80. PubMed ID: 1923952
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
Tulipano G; Bonfanti C; Milani G; Billeci B; Bollati A; Cozzi R; Maira G; Murphy WA; Poiesi C; Turazzi S; Giustina A
Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
